Notably, ILF3-KD tumors showed a pronounced decrease in the serine, glycine and SAM biosynthesis rates and subsequent GSH/GSSG ratios in the tumor mass (Fig. 6g, h). The gene discussed is ILF3; the disease is neoplasm.